Attenuation of neurodegeneration-relevant modifications of brain proteins by dietary soy.

Epidemiological studies show that postmenopausal women who undertake estrogen-replacement therapy have significantly lower risk for the onset of Alzheimer's disease (AD) than women who do not. Animal behavior studies have shown that ovariectomy results in the development of cognitive dysfunction that is prevented by estrogen-replacement, suggesting that normal mammalian cognitive function is impaired by estrogen reduction. Soy isoflavones in particular genistein have been demonstrated to have weak and selective estrogenic actions in various models of human chronic diseases. A hallmark of several human dementias including AD and fronto temporal dementia with Parkinsonism on chromosome 17 (FTDP-17) is the hyperphosphorylation of the microtubule-associated protein tau. Preliminary experiments are discussed here which show that isoflavones delivered in a soy protein matrix attenuated selected AD-relevant tau phosphorylations in a primate model of menopause. The rationale is discussed for the use of soy-based foods for protection against postmenopausal neurodegeneration.

[1]  Christina A. Wilson,et al.  Intracellular APP Processing and Aβ Production in Alzheimer Disease , 1999 .

[2]  H. Towbin,et al.  Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. , 1979, Proceedings of the National Academy of Sciences of the United States of America.

[3]  A. Frankfurter,et al.  The distribution of tau in the mammalian central nervous system , 1985, The Journal of cell biology.

[4]  K. Grandien,et al.  Printed in U.S.A. Copyright © 1997 by The Endocrine Society Comparison of the Ligand Binding Specificity and Transcript Tissue Distribution of Estrogen Receptors � and � , 2022 .

[5]  H. Kim.  Depletion of acetylated α‐tubulin during microtubule purification from bovine brain gray and white matter regions , 1991, Journal of neuroscience research.

[6]  P. Davies,et al.  Hydrofluoric acid-treated tau PHF proteins display the same biochemical properties as normal tau. , 1992, The Journal of biological chemistry.

[7]  J. Cline,et al.  The Potential of Soybean Phytoestrogens for Postmenopausal Hormone Replacement Therapy , 1998, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[8]  A. Klug,et al.  Correlation between structural transformation and cleavage of the major head protein of T4 bacteriophage , 1976, Cell.

[9]  S. Barnes,et al.  The role of soy products in reducing risk of cancer. , 1991, Journal of the National Cancer Institute.

[10]  N. Sathyamoorthy,et al.  Differential effect of genistein on transforming growth factor beta 1 expression in normal and malignant mammary epithelial cells. , 1998, Anticancer research.

[11]  A. Takashima,et al.  Activation of tau protein kinase I/glycogen synthase kinase-3β by amyloid β peptide (25–35) enhances phosphorylation of tau in hippocampal neurons , 1998, Neuroscience Research.

[12]  J. Trojanowski,et al.  Epitopes that span the tau molecule are shared with paired helical filaments , 1988, Neuron.

[13]  J. Gustafsson,et al.  Cloning of a novel receptor expressed in rat prostate and ovary. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[14]  C. Lamartiniere,et al.  Genistein, a component of soy, inhibits the expression of the EGF and ErbB2/Neu receptors in the rat dorsolateral prostate , 1998, The Prostate.

[15]  K. Welsh-Bohmer,et al.  Enhanced Cognitive Performance with Estrogen Use in Nondemented Community‐Dwelling Older Women , 1999, Journal of the American Geriatrics Society.

[16]  Meharvan Singh,et al.  Novel Mechanisms of Estrogen Action in the Brain: New Players in an Old Story , 1999, Frontiers in Neuroendocrinology.

[17]  S. Barnes,et al.  Mechanisms of action of the soy isoflavone genistein: emerging role for its effects via transforming growth factor beta signaling pathways. , 1998, The American journal of clinical nutrition.

[18]  C. Beyer.  Estrogen and the developing mammalian brain , 1999, Anatomy and Embryology.

[19]  Estrogen Replacement Therapy and Cognitive Decline in Older Community Women , 1999, Journal of the American Geriatrics Society.

[20]  K. Wilhelmsen.  The tangled biology of tau. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[21]  S. Barnes,et al.  Variable effects of tyrosine kinase inhibitors on avian osteoclastic activity and reduction of bone loss in ovariectomized rats , 1996, Journal of cellular biochemistry.

[22]  K. Yaffe,et al.  Estrogen therapy in postmenopausal women: effects on cognitive function and dementia. , 1998, JAMA.

[23]  D. Salmon,et al.  The prevalence of dementia and Alzheimer's disease in Shanghai, China: Impact of age, gender, and education , 1990, Annals of neurology.

[24]  N. Cairns,et al.  Tau proteins of alzheimer paired helical filaments: Abnormal phosphorylation of all six brain isoforms , 1992, Neuron.

[25]  L. Raisz.  Osteoporosis: Current approaches and future prospects in diagnosis, pathogenesis, and management , 1999, Journal of Bone and Mineral Metabolism.

[26]  M. Hutton,et al.  Accelerated filament formation from tau protein with specific FTDP‐17 missense mutations , 1999, FEBS letters.

[27]  K. Setchell,et al.  Dietary isoflavones: biological effects and relevance to human health. , 1999, The Journal of nutrition.

[28]  W. Blackstock,et al.  New Phosphorylation Sites Identified in Hyperphosphorylated Tau (Paired Helical Filament‐Tau) from Alzheimer's Disease Brain Using Nanoelectrospray Mass Spectrometry , 1998, Journal of neurochemistry.

[29]  B. McEwen.  The Molecular and Neuroanatomical Basis for Estrogen Effects in the Central Nervous System , 1999 .

[30]  S. Barnes,et al.  Chlorination and nitration of soy isoflavones. , 1999, Archives of biochemistry and biophysics.

[31]  J. Corton,et al.  Interaction of Estrogenic Chemicals and Phytoestrogens with Estrogen Receptor β. , 1998, Endocrinology.

[32]  G. Rosano,et al.  Oestrogens and the heart. , 1999, Therapie.

[33]  Yaakov Stern,et al.  Effect of oestrogen during menopause on risk and age at onset of Alzheimer's disease , 1996, The Lancet.

[34]  J. D. Wagner,et al.  Soy protein versus soy phytoestrogens in the prevention of diet-induced coronary artery atherosclerosis of male cynomolgus monkeys. , 1997, Arteriosclerosis, thrombosis, and vascular biology.

[35]  P. Greengard,et al.  Estrogen reduces neuronal generation of Alzheimer β-amyloid peptides , 1998, Nature Medicine.

[36]  M. Shibuya,et al.  Genistein, a specific inhibitor of tyrosine-specific protein kinases. , 1987, The Journal of biological chemistry.

[37]  R Brookmeyer,et al.  Projections of Alzheimer's disease in the United States and the public health impact of delaying disease onset. , 1998, American journal of public health.

[38]  E. Barrett-Connor,et al.  Gender Differences in Cognitive Function with Age: The Rancho Bernardo Study , 1999, Journal of the American Geriatrics Society.

[39]  W. Schaffner,et al.  Phytoestrogen kaempferol (3,4′,5,7‐tetrahydroxyflavone) protects PC12 and T47D cells from β‐amyloid–induced toxicity , 1999, Journal of neuroscience research.

[40]  M. Goedert,et al.  Tau protein pathology in neurodegenerative diseases , 1998, Trends in Neurosciences.

[41]  L. Katz,et al.  Effect of Estrogen on Brain Activation Patterns in Postmenopausal Women During Working Memory Tasks , 1999 .

[42]  M A Espeland,et al.  The Women's Health Initiative Memory Study (WHIMS): a trial of the effect of estrogen therapy in preventing and slowing the progression of dementia. , 1998, Controlled clinical trials.